2014115-Surajit Pal of Prabhudas Lilladher feels the pharma companys US sales will take atleast 18 months to recover. He fears that if USFDA issue
2017125-USFDA issues warning letter to Lupins Goa, Indore plants news and related update by Business Standard USFDA issued a warning letter to L
Calcutta Telegraph Street undeterred by USFDA observations on Lupins Indore plant Business Standard Last week, Lupin announced developments on two respirator
201395-This is an establishment approval so it is a final approval from the US Food and Drug Administration (USFDA) for the Indore SEZ plant. Ipca
Lupin said its Indore plant was audited by the US Food and Drug The company said it has received approval from the USFDA to market
20171116-Read more about USFDA issues warning letter to Lupins Goa, Indore plants on Business Standard. The US Food and Drug Administration (USFDA)
Metal Oil and Gas Pharma Retail Technology Textile Economy India Industry Agriculture Automobile Consumer Goods Digital Financial FMCG Healthcare Tel
iGrow-USFDA Approved Hair Regrowth System - Find Health, Beauty Fitness service in Anoop Nagar Indore. Post free classified ads for Health, Beauty
20171116-On Lupins Pithampur (Indore) plant, the US health regulator said the company invalidated initial OOS laboratory results without adequate in
20171013-Cipla remains amongst the few large domestic companies that has so far not faced tough regulatory actions from the US FDA. SECTIONS ET AP
Moneycontrol.com Cipla gets FDAs nine observations and issues noticed memo for Indore unit Economic Times MUMBAI: Indian drug maker Cipla has been served
USFDA raises concerns over Lupins Indore plant Business Standard Drug major Lupin today said the US health regulator has raised concerns over compliance
Indore, USFDA, EIR, Cipla, JUST NOW, Get all the Latest news, Breaking headlines and Top stories, photos video in real time about ET NOW Fin
Glenmark has received 3 observations from USFDA for Indore plant to the observations issued by the US Food and Drug Administration (USFDA)
20171116-The US Food and Drug Administration (USFDA) has issued a warning letter to Lupin for violation of current good manufacturing practice norms
Cipla receives EIR from the US FDA for its Indore facility News Policy Regulatory Finance Company World Science Supplier People Academics Op
Cipla receives EIR Report from USFDA for Indore facility-Drug major Cipla today said it has received Establishment Inspection Report from the US health
FDA seizes 2000 kg mawa substitute worth Rs 4.80 lakh in Indore Times of India INDORE: In its on-going drive to curb adulterated food items supply
2011617-The U.S. Food and Drug Administration (FDA) inspected your drug 2, SEZ Phase-II, Misc., Apparel Park, District Dhar, Pithampur, Indore,
2015223-Drug major Lupin today said the US health regulator has raised concerns over compliance norms at its manufacturing plant in Indore that prod
Live Radio Opinion Poll Careers Feedback Market Stats BSE Sensex BSE 100 BSE 200 BSE 500 BSE TECK BSE PSU BSE BANKEX BSE Midcap
2018416-USFDA conducts inspection at Ciplas Indore facility Indore facility and has not issued any data (USFDA) conducted a routine current Go
Top 100 Superstars Top 50 Superstars Portfolio Managers Portfolio WatchList EvaluatedListComPeer ComPeer Screeners Price Chart Filter Decisio
Press ReleaseCipla receives EIR from the US FDA for its Indore facility India, Mumbai, October 12, 2016: Cipla Limited today announ Lifestyle Ar
Pharmaceuticals from the US health regulator for its Pithampur, Indore plant.to the observations issued by the US Food and Drug Administration (USFDA)
2018814-Cipla: US FDA cloud over Indore plant clears news and related update by livemint Cipla: US FDA cloud over Indore plant clears livemint C
2015519-FDA moves to check sale of banned energy drinks in IndoreINDORE: Soon after Food Safety and Standards Authority of India (FSSAI) ordered an
20171116-The US Food and Drug Administration (USFDA) has issued a warning letter to Lupin for violation of current good manufacturing practice norms
2016421-Glenmark gets 3 observations from USFDA for Indore plant - The company said it has responded to the observations made by the USFDA after the
The report indicates formal closure of the USFDA inspection conducted in July/August, 2015 Top 100 Superstars Top 50 Superstars Portfolio Managers P